| Literature DB >> 31559458 |
Yuji Kono1,2, Hideo Izawa3, Yoichiro Aoyagi2, Ayako Ishikawa1, Tsubasa Sugiura1, Etsuko Mori1, Ryuzo Yanohara1, Tomoya Ishiguro4, Ryo Yamada4, Satoshi Okumura4, Wakaya Fujiwara4, Mutsuharu Hayashi4, Eiichi Saitoh2.
Abstract
The aim of this study was to determine whether early mobilization was associated with rehospitalization among elderly heart failure patients. We measured the time from admission to mobilization and other clinical characteristics for 190 heart failure patients (mean age, 80.7 years). The primary outcome was heart failure rehospitalization. Kaplan-Meier survival curves were plotted and the hazard ratios for rehospitalization were determined using Cox proportional hazards regression models. During a median follow-up period of 750 days, 58 patients underwent rehospitalization. The time from admission to mobilization was significantly longer for these patients than for those who were not rehospitalized. Univariate and multivariate Cox proportional hazards analyses showed that the time from admission to mobilization was an independent predictor of rehospitalization, and receiver-operating characteristic analysis determined an optimal cutoff value of 3 days for differentiating the patients more likely to experience a subsequent cardiac event (sensitivity, 76%; specificity, 69%; area under the curve, 0.667). Kaplan-Meier survival curve analysis showed a significantly lower event rate in the ≤ 3-day group (p = 0.001, log-rank test). In conclusion, the time from admission to mobilization may be one of the strongest predictors of rehospitalization in elderly heart failure patients. Early mobilization within 3 days may be an initial target for the acute phase treatment of heart failure.Entities:
Keywords: Acute heart failure; Elderly; Mobilization; Rehospitalization
Mesh:
Year: 2019 PMID: 31559458 PMCID: PMC7222093 DOI: 10.1007/s00380-019-01517-8
Source DB: PubMed Journal: Heart Vessels ISSN: 0910-8327 Impact factor: 2.037
Demographic and clinical characteristics of the rehospitalization and non-rehospitalization groups
| Total | Rehospitalization | Non-rehospitalization | ||
|---|---|---|---|---|
| Age | 80.7 (8.5) | 79.8 (8.3) | 81.2 (8.6) | 0.298 |
| Gender (M/F) | 79/111 | 17/41 | 62/70 | 0.095 |
| BMI (kg/m2) | 20.9 (3.4) | 20.1 (3.1) | 21.3 (3.5) | < 0.001 |
| SBP at admission (mmHg) | 140 (30.5) | 134 (32.3) | 142 (29.4) | 0.262 |
| Admission to mobilization days | 4.2 (2.8) | 5.1 (3.5) | 3.9 (2.4) | 0.006 |
| MMSE | 24.5 (4.9) | 23.9 (5.4) | 24.6 (4.7) | 0.429 |
| GNRI | 92.8 (11.9) | 89.1 (10.2) | 93.5 (11.2) | 0.010 |
| Cause of heart failure (%) | 0.353 | |||
| Ischemic cardiomyopathy | 28.4 | 36.2 | 25.0 | |
| Dilated cardiomyopathy | 30.0 | 29.3 | 30.3 | |
| Hypertensive cardiomyopathy | 16.3 | 12.0 | 18.2 | |
| Arrythmia | 16.3 | 13.7 | 17.4 | |
| Others | 9.0 | 8.8 | 9.1 | |
| Comorbidities (%) | ||||
| Hypertension | 52.1 | 49.3 | 55.3 | 0.175 |
| Diabetes | 37.8 | 31.1 | 38.6 | 0.695 |
| CKD | 59.4 | 62.0 | 58.3 | 0.437 |
| Stroke | 14.2 | 16.8 | 16.6 | 0.363 |
| Pharmacotherapy (%) | ||||
| ACEi/ARB | 50.5 | 46.5 | 52.2 | 0.443 |
| β-blocker | 80.0 | 81.0 | 79.1 | 0.331 |
| Diuretics | 82.6 | 89.6 | 79.5 | 0.386 |
| Statin | 25.7 | 32.7 | 22.7 | 0.303 |
| Oral diabetic agent | 17.8 | 22.4 | 15.9 | 0.513 |
| Serum hemoglobin (g/dl) | 11.7 (2.1) | 11.2 (1.8) | 11.9 (2.1) | 0.023 |
| Serum albumin (g/dl) | 3.5 (0.5) | 3.4 (0.5) | 3.6 (0.5) | 0.071 |
| Serum Sodium (mEq/l) | 139 (4.4) | 139 (4.5) | 139 (4.5) | 0.996 |
| eGFR | 45.3 (19.4) | 41.4 (20.7) | 47.1 (18.6) | 0.065 |
| NT-proBNP (pg/ml) | 6965 (8021) | 9820 (9018) | 5711 (7228) | 0.001 |
| LVEF (%) | 53.9 (18.2) | 49.4 (20.7) | 55.6 (16.4) | 0.030 |
| Grip (kg) | 19.2 (7.4) | 18.1 (6.1) | 19.7 (7.9) | 0.116 |
| 6-min walking distance (m) | 272 (121) | 265 (113) | 276 (125) | 0.563 |
| Walking speed (m/s) | 0.85 (0.32) | 0.87 (0.31) | 0.85 (0.33) | 0.476 |
Data are presented as mean (standard deviation)
BMI body mass index, SBP systolic blood pressure, MMSE mini-mental state examination, GNRI geriatric nutritional risk index, CKD chronic kidney disease, ACEi angiotensin-converting enzyme inhibitor, ARB angiotensin II type I receptor blocker, eGFR estimated glomerular filtration rate, NT-proBNP N-terminal pro B-type natriuretic peptide, LVEF left ventricular ejection fraction
Univariate and multivariate cox regression hazard models for rehospitalization, with admission to mobilization time as the independent factor
| SE | Wald | HR | 95% CI | ||||
|---|---|---|---|---|---|---|---|
| Lower | Upper | ||||||
| Univariable | 0.087 | 0.039 | 5.01 | 0.025 | 1.091 | 1.011 | 1.177 |
| Multivariable | |||||||
| Model 1 | 0.084 | 0.039 | 4.585 | 0.032 | 1.088 | 1.007 | 1.175 |
| Model 2 | 0.080 | 0.039 | 4.183 | 0.041 | 1.084 | 1.003 | 1.170 |
| Model 3 | 0.083 | 0.040 | 4.355 | 0.037 | 1.086 | 1.005 | 1.174 |
Adjusted models: Model 1, included log (NT-proBNP); Model 2, Model 1 + eGFR; Model 3, Model 2 + potential confounding factor (gender, LVEF, GNRI, serum hemoglobin)
HR hazard ratio, NT-proBNP N-terminal pro B-type natriuretic peptide, eGFR estimated glomerular filtration rate
Fig. 1Receiver-operating characteristic (ROC) analysis of the time from admission to mobilization (in days) as a predictor of cardiac events during the follow-up period. The optimal cutoff value for distinguishing subjects who would experience a later cardiac event was 3 days. This cutoff gave a sensitivity of 76.2% and a specificity of 62.1%; the area under the curve was 0.667 (95% CI 0.577–0.743, p < 0.001)
Fig. 2Kaplan–Meier survival curves for the period (in days) to a cardiac event. The subjects were divided into two groups according to whether the time between admission and mobilization was ≤ 3 days (blue curve) or ≥ 4 days (green curve). There was a significantly lower incidence of cardiac events in the group with earlier mobilization (log rank = 11.442, p = 0.001)